NEW YORK, Sept. 14, 2017 -- Guggenheim Investments, the investment management division of Guggenheim Partners, today announced that the following Guggenheim equity exchange traded funds (“ETFs”) have declared quarterly distributions. The table below summarizes the distribution for each Fund.
| Distributions Schedule | ||||||
| Ticker | Exchange Traded Fund Name | Ex-Date | Record Date | Payable Date | Total Rate Per Share | |
| XLG | Guggenheim S&P 500® Top 50 ETF | 9/15/17 | 9/18/17 | 9/29/17 | $0.938 | |
| RSP | Guggenheim S&P 500® Equal Weight ETF | 9/15/17 | 9/18/17 | 9/29/17 | $0.410 | |
| OEW | Guggenheim S&P 100® Equal Weight ETF | 9/15/17 | 9/18/17 | 9/29/17 | $0.122 | |
| RPV | Guggenheim S&P 500® Pure Value ETF | 9/15/17 | 9/18/17 | 9/29/17 | $0.302 | |
| RPG | Guggenheim S&P 500® Pure Growth ETF | 9/15/17 | 9/18/17 | 9/29/17 | $0.216 | |
| RFV | Guggenheim S&P MidCap 400® Pure Value ETF | 9/15/17 | 9/18/17 | 9/29/17 | $0.228 | |
| RFG | Guggenheim S&P MidCap 400® Pure Growth ETF | 9/15/17 | 9/18/17 | 9/29/17 | $0.222 | |
| RZV | Guggenheim S&P SmallCap 600® Pure Value ETF | 9/15/17 | 9/18/17 | 9/29/17 | $0.218 | |
| RZG | Guggenheim S&P SmallCap 600® Pure Growth ETF | 9/15/17 | 9/18/17 | 9/29/17 | $0.102 | |
| RTM | Guggenheim S&P 500® Equal Weight Materials ETF | 9/15/17 | 9/18/17 | 9/29/17 | $0.428 | |
| RGI | Guggenheim S&P 500® Equal Weight Industrials ETF | 9/15/17 | 9/18/17 | 9/29/17 | $0.463 | |
| RYT | Guggenheim S&P 500® Equal Weight Technology ETF | 9/15/17 | 9/18/17 | 9/29/17 | $0.297 | |
| Distributions Schedule | ||||||
| Ticker | Exchange Traded Fund Name | Ex-Date | Record Date | Payable Date | Total Rate Per Share | |
| RYH | Guggenheim S&P 500® Equal Weight Health Care ETF | 9/15/17 | 9/18/17 | 9/29/17 | $0.254 | |
| RHS | Guggenheim S&P 500® Equal Weight Consumer Staples ETF | 9/15/17 | 9/18/17 | 9/29/17 | $0.637 | |
| RCD | Guggenheim S&P 500® Equal Weight Consumer Discretionary ETF | 9/15/17 | 9/18/17 | 9/29/17 | $0.380 | |
| RYE | Guggenheim S&P 500® Equal Weight Energy ETF | 9/15/17 | 9/18/17 | 9/29/17 | $0.767 | |
| RYF | Guggenheim S&P 500® Equal Weight Financials ETF | 9/15/17 | 9/18/17 | 9/29/17 | $0.147 | |
| RYU | Guggenheim S&P 500® Equal Weight Utilities ETF | 9/15/17 | 9/18/17 | 9/29/17 | $0.674 | |
| EWRE | Guggenheim S&P 500® Equal Weight Real Estate ETF | 9/15/17 | 9/18/17 | 9/29/17 | $0.159 | |
| EWMC | Guggenheim S&P MidCap 400® Equal Weight ETF | 9/15/17 | 9/18/17 | 9/29/17 | $0.173 | |
| EWSC | Guggenheim S&P SmallCap 600® Equal Weight ETF | 9/15/17 | 9/18/17 | 9/29/17 | $0.127 | |
| GMFL | Guggenheim Multi-Factor Large Cap ETF | 9/15/17 | 9/18/17 | 9/29/17 | $0.439 | |
| EWEM | Guggenheim MSCI Emerging Markets Equal Country Weight ETF | 9/15/17 | 9/18/17 | 9/29/17 | $0.212 | |
Past performance is not indicative of future performance. To the extent any portion of the distribution is estimated to be sourced from something other than income, such as return of capital, the source would be disclosed on a Section 19(a)-1 letter located on the Fund’s website under the “Literature” tab. Distributions may be comprised of sources other than income, which may not reflect actual Fund performance.
For more information, please visit http://www.guggenheiminvestments.com/etf.
About Guggenheim Investments
Guggenheim Investments is the global asset management and investment advisory division of Guggenheim Partners, with more than $237 billion1 in total assets across fixed income, equity, and alternative strategies. We focus on the return and risk needs of insurance companies, corporate and public pension funds, sovereign wealth funds, endowments and foundations, consultants, wealth managers, and high-net-worth investors. Our 275+ investment professionals perform rigorous research to understand market trends and identify undervalued opportunities in areas that are often complex and underfollowed. This approach to investment management has enabled us to deliver innovative strategies providing diversification and attractive long-term results.
Media Contact
Ivy McLemore
Director of Intermediary Communications
Guggenheim Investments
[email protected]
(212) 518-9859
Read a fund’s prospectus and summary prospectus (if available) carefully before investing. It contains the fund’s investment objectives, risks, charges, expenses and other information, which should be considered carefully before investing. Obtain a prospectus and summary prospectus (if available) at http://guggenheiminvestments.com or call 800.820.0888.
The referenced funds are distributed by Guggenheim Funds Distributors, LLC. Guggenheim Investments represents the investment management business of Guggenheim Partners, LLC (“Guggenheim”), which includes Guggenheim Funds Investment Advisors (“GFIA”), Security Investors, LLC (“SI”), the investment advisors to the referenced fund. Guggenheim Funds Distributors, LLC is affiliated with Guggenheim, SI, and GFIA.
1Guggenheim Investments total asset figure is as of 06.30.2017. The assets include leverage of $11.3bn for assets under management and $0.4bn for assets for which we provide administrative services. Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Real Estate, LLC, GS GAMMA Advisors, LLC, Guggenheim Partners Europe Limited, and Guggenheim Partners India Management.


Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Italy Fines Apple €98.6 Million Over App Store Dominance
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
FDA Approves Mitapivat for Anemia in Thalassemia Patients
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 



